MALLORI HATHAWAY: Open Payments
NPI 1861019689 · SCOTTSBURG, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$851 in 47 payments from 11 companies in 2025. Trend: 2023 $280 · 2024 $758 · 2025 $851
Food & beverage: $751Education: $100
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 15 | $205 |
| Janssen Biotech, Inc. | 10 | $173 |
| Novartis Pharmaceuticals Corporation | 7 | $133 |
| UCB, Inc. | 3 | $92 |
| Regeneron Healthcare Solutions, Inc. | 3 | $79 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 2 | $38 |
| Incyte Corporation | 2 | $37 |
| LEO Pharma Inc. | 2 | $33 |
| Verrica Pharmaceuticals Inc. | 1 | $22 |
| E.R. Squibb & Sons, L.L.C. | 1 | $19 |
Products named: TREMFYA, SKYRIZI, Bimzelx, DUPIXENT, RINVOQ, COSENTYX, Winlevi, OPZELURA.
Industry payments across IN — which companies pay providers there.
